Gene · 1806
NIH grants1,496
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,496
Download this page as JSON| Grant | Title | DPYD papers | Newest fiscal year |
|---|---|---|---|
| R01AA027486 | Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics | 1 | 2025 |
| R01AG069453 | APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease | 1 | 2025 |
| R01AI077505 | Pharmacogenomics of HIV Therapy | 1 | 2025 |
| R01AI141009 | Role of clonal expansion in HIV-1 persistence | 1 | 2025 |
| R01CA102184 | Functional Analysis of p53 Polymorphic Variants | 1 | 2025 |
| R01CA134675 | Enhanced imaging and treatment of aggressive subtypes of prostate cancer | 1 | 2025 |
| R01CA148761 | Therapeutic Targeting of Breast Cancer Tumor Initiating Cells | 1 | 2025 |
| R01CA164719 | Anti-cancer vaccine targeting the host-parasite interface during fluke infection | 1 | 2025 |
| R01CA220468 | Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response | 1 | 2025 |
| R01CA255116 | Metabolism of cancer chemotherapeutics by the human gut microbiome | 1 | 2025 |
| R01CA258586 | Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy | 1 | 2025 |
| R01CA262425 | Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer | 1 | 2025 |
| R01CA276178 | Integrated blood and radiomic subtyping to guide immunotherapy treatment selection and early response assessment in metastatic non-small cell lung cancer | 1 | 2025 |
| R01DK052230 | Regulation of Intestinal Epithelial Cell Proliferation | 1 | 2025 |
| R01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 1 | 2025 |
| R01DK075787 | Biological Insights from Genetic Investigation of ANthropometric Traits (GIANT) Across the Allelic Spectrum | 1 | 2025 |
| R01DK115679 | Nutrigenetics and Nutrigenomics for Precision Weight-Loss Diet Interventions | 1 | 2025 |
| R01DK129552 | Deciphering Epithelial Signals in the Liver to Drive Inflammation and Fibrosis | 1 | 2025 |
| R01EB006841 | Multivariate methods for identifying multitask/multimodal brain imaging biomarkers | 1 | 2025 |
| R01GM102187 | Chemical Tools for Probing Cysteine Sulfenation and Sulfination Redox Biology | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/grants?page=8